Search Results - "Ferro, JM"

Refine Results
  1. 1

    Poststroke epilepsy: Epidemiology, pathophysiology and management by FERRO, José M, PINTO, Francisco

    Published in Drugs & aging (01-01-2004)
    “…Seizures and status epilepticus can be a presenting feature of acute stroke. They may occur in its early (<7 days) clinical course or be a remote (>7 days)…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Cardioembolic stroke: an update by Ferro, José M

    Published in Lancet neurology (01-03-2003)
    “…Embolism of cardiac origin accounts for about one fifth of ischaemic strokes. Strokes due to cardioembolism are in general severe and prone to early…”
    Get more information
    Journal Article
  5. 5

    A multivariate study of headache associated with ischemic stroke by Ferro, J M, Melo, T P, Oliveira, V, Salgado, A V, Crespo, M, Canhão, P, Pinto, A N

    Published in Headache (01-06-1995)
    “…Thirty-four percent of 182 ischemic stroke patients registered during 1 year in a prospective hospital stroke data base complained of headache within a 72-hour…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Prognosis of cerebral vein and dural sinus thrombosis: Results of the international study on cerebral vein and dural sinus thrombosis (ISCVT) by FERRO, José M, CANHAO, Patricia, STAM, Jan, BOUSSER, Marie-Germaine, BARINAGARREMENTERIA, Fernando

    Published in Stroke (1970) (01-03-2004)
    “…The natural history and long-term prognosis of cerebral vein and dural sinus thrombosis (CVT) have not been examined previously by adequately powered…”
    Get full text
    Journal Article
  8. 8

    Physical activity in vascular cognitive impairment: Systematic review with meta-analysis by Vítor, Joana, Melita, Catarina, Rodrigues, Mário, de Sousa, Diana Aguiar, Costa, João, Ferro, JM, Verdelho, Ana

    “…Vascular cognitive impairment (VCI) is the second most common cause of cognitive impairment worldwide and includes a spectrum from vascular cognitive…”
    Get full text
    Journal Article
  9. 9

    Association of gait and balance disorders with age-related white matter changes : The LADIS Study by BAEZNER, H, BLAHAK, C, O'BRIEN, J, SCHELTENS, P, VISSER, M. C, WAHLUND, L. O, WALDEMAR, G, WALLIN, A, HENNERICI, M. G, POGGESI, A, PANTONI, L, INZITARI, D, CHABRIAT, H, ERKINJUNTTI, T, FAZEKAS, F, FERRO, J. M, LANGHORNE, P

    Published in Neurology (18-03-2008)
    “…In the Leukoaraiosis and Disability (LADIS) Study, 11 European centers are evaluating the role of age-related white matter changes (ARWMC) as an independent…”
    Get full text
    Journal Article
  10. 10

    White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study by VERDELHO, A, MADUREIRA, S, WALLIN, A, HENNERICI, M, INZITARI, D, MOLEIRO, C, FERRO, J. M, SANTOS, C. O, ERKINJUNTTI, T, PANTONI, L, FAZEKAS, F, VISSER, M, WALDEMAR, G

    Published in Neurology (13-07-2010)
    “…We aimed to study if age-related white matter changes (WMC) and vascular risk factors were predictors of cognitive decline in elderly subjects with WMC living…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion by Diener, HC, Bernstein, R, Butcher, K, Campbell, B, Cloud, G, Davalos, A, Davis, S, Ferro, JM, Grond, M, Krieger, D, Ntaios, G, Slowik, A, Touzé, E

    Published in International journal of stroke (01-01-2017)
    “…Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides…”
    Get full text
    Journal Article
  13. 13

    Incident lacunes influence cognitive decline: The LADIS study by JOKINEN, H, GOUW, A. A, VERDELHO, A, FERRO, J. M, PANTONI, L, INZITARI, D, ERKINJUNTTI, T, MADUREIRA, S, YLIKOSKI, R, VAN STRAATEN, E. C. W, VAN DER FLIER, W. M, BARKHOF, F, SCHELTENS, P, FAZEKAS, F, SCHMIDT, R

    Published in Neurology (31-05-2011)
    “…In cerebral small vessel disease, the core MRI findings include white matter lesions (WML) and lacunar infarcts. While the clinical significance of WML is…”
    Get full text
    Journal Article
  14. 14

    Causes and predictors of death in cerebral venous thrombosis by CANHAO, Patricia, FERRO, José M, LINDGREN, Arne G, BOUSSER, Marie-Germaine, STAM, Jan, BARINAGARREMENTERIA, Fernando

    Published in Stroke (1970) (01-08-2005)
    “…The causes of death of patients with cerebral venous thrombosis (CVT) have not been systematically addressed in previous studies. We aimed to analyze the…”
    Get full text
    Journal Article
  15. 15

    ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case–control study by Ken-Dror, Gie, Sharma, Pankaj, van de Munckhof, Anita, Krzywicka, Katarzyna, van Kammen, Mayte Sánchez, Ghoreishi, Abdoreza, Borhani-Haghighi, Afshin, Negro, Alberto, Günther, Albrecht, Cervera, Alvaro, Tuladhar, Anil Man, Devroye, Annemie, Mengel, Annerose, Aujayeb, Avinash, Casolla, Barbara, Chew, Beng Lim Alvin, Zanferrari, Carla, Garcia-Esperon, Carlos, Wahl, Christoph M., Alonso, Daniel Guisado, Bougon, David, Zimatore, Domenico Sergio, Michalski, Dominik, Blacquiere, Dylan, Johansson, Elias, Cuadrado-Godia, Elisa, de Maistre, Emmanuel, Kristoffersen, Espen Saxhaug, Bonneville, Fabrice, Giammello, Fabrizio, D'Onofrio, Florindo, Grillo, Francesco, Tsivgoulis, Georgios, Sibon, Igor, Masjuan, Jaime, Duan, Jiangang, Burrow, Jim, Pelz, Johann, Mbroh, Joshua, Ng, Karl, Garambois, Katia, Lagarde, Kevin, Lanthier, Sylvain, Pérez, María Hernández, Sharma, Aarti R, Sharma, Shyam S, Morín, Mar, Petruzzellis, Marco, Cotelli, Maria Sofia, Zedde, Marialuisa, Carvalho, Marta, Wittstock, Matthias, Roozbeh, Mehrdad, Miranda, Miguel, Wronski, Miriam, Skjelland, Mona, di Poggio, Monica Bandettini, Almasi-Dooghaee, Mostafa, Raposo, Nicolas, Fadakar, Nima, Kruyt, Nyika, Candelaresi, Paolo, Vieira, Ricardo, Acampora, Roberto, Lemmens, Robin, Kern, Rolf, Murphy, Seán, Nagel, Simon, Hiltunen, Sini, Chatterton, Sophie, Karapanayiotides, Theodoros, Cox, Thomas, Gattringer, Thomas, Geeraerts, Thomas, Bartsch, Thorsten, Mirzaasgari, Zahra, Ziaadini, Bentalhoda, Zamani, Zohreh, Field, Thalia S, Cordonnier, Charlotte, Kleinig, Timothy J, Putaala, Jukka, Poli, Sven, Scutelnic, Adrian, Heldner, Mirjam R, Lindgren, Erik, Tatlisumak, Turgut, Jood, Katarina, Arnold, Marcel, de Sousa, Diana Aguiar, Ferro, Jose M, Coutinho, Jonathan M

    Published in Journal of the Royal Society of Medicine (01-02-2024)
    “…Objectives To determine whether blood group influences development of cerebral venous thrombosis (CVT) after administration of the coronavirus disease 2019…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Triflusal for preventing serious vascular events in people at high risk by Costa, J, Ferro, J M, Matias-Guiu, J, Alvarez-Sabin, J, Torres, F

    Published in Cochrane database of systematic reviews (20-07-2005)
    “…Aspirin is the standard treatment for secondary prevention of stroke and other vascular events. Several studies suggest that triflusal may have a better safety…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study by Teodorczuk, A, Firbank, M J, Pantoni, L, Poggesi, A, Erkinjuntti, T, Wallin, A, Wahlund, L-O, Scheltens, P, Waldemar, G, Schrotter, G, Ferro, J M, Chabriat, H, Bazner, H, Visser, M, Inzitari, D, O'Brien, J T

    Published in Psychological medicine (01-04-2010)
    “…Growing evidence suggests that cerebral white-matter changes and depressive symptoms are linked directly along the causal pathway. We investigated whether…”
    Get more information
    Journal Article
  20. 20

    Thrombolytics for cerebral sinus thrombosis: a systematic review by Canhão, Patricia, Falcão, Filipa, Ferro, José M

    “…The use of thrombolytics is frequently mentioned in patients with cerebral venous or dural sinus thrombosis (CVDST) who deteriorate despite anticoagulant…”
    Get more information
    Journal Article